A Transformative Therapy Value Model for Rare Blood Diseases
January 10, 2020
Marwood had the privilege of working with the Alliance for Regenerative Medicine to assess the long-term value and cost-savings associated with durable and potentially curative cell and gene therapies. To inquire about Marwood’s work in regenerative medicine, please contact firstname.lastname@example.org
Navigating Provider Challenges to Growth of The CAR T-Cell Therapy Space
January 7, 2020
Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in personalized cancer treatment. Click the link provided to read our full report.
Fertile Grounds: Evolution in the Global Assisted Reproductive Technology Sector
October 7, 2019
The assisted reproductive technology (ART) / fertility sector has consistently developed new technology, improved clinical outcomes, and created significant financial returns for investors over a 40-year period. The $6B+ US market continues to grow rapidly and prospects for continued worldwide growth are strong. However, investors must be mindful of disruptive evolution in a market where scientific advances can rapidly alter the business landscape, and long-term growth may be offset by increased success rates.
European Fact Files – 2019
June 3, 2019
With voters heading to the polls in several countries later this year, the European political map may have shifted substantially by the end of 2019. Alongside this the European Parliament elections in May will also act as a key marker to the extent to which populist parties are gaining ground. Meanwhile, Brexit continues to cast a long shadow over the UK’s relationship with the European Union.